These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

999 related items for PubMed ID: 15955168

  • 21. Serological and genetic factors in early recurrence of IgA nephropathy after renal transplantation.
    Coppo R, Amore A, Chiesa M, Lombardo F, Cirina P, Andrulli S, Passerini P, Conti G, Peruzzi L, Giraudi R, Messina M, Segoloni G, Ponticelli C.
    Clin Transplant; 2007; 21(6):728-37. PubMed ID: 17988266
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Mesangial C4d deposition: a new prognostic factor in IgA nephropathy.
    Espinosa M, Ortega R, Gómez-Carrasco JM, López-Rubio F, López-Andreu M, López-Oliva MO, Aljama P.
    Nephrol Dial Transplant; 2009 Mar; 24(3):886-91. PubMed ID: 18842673
    [Abstract] [Full Text] [Related]

  • 24. HLA-B8, DR3: a new risk factor for graft failure after renal transplantation in patients with underlying immunoglobulin A nephropathy.
    Andresdottir MB, Haasnoot GW, Persijn GG, Claas FH.
    Clin Transplant; 2009 Mar; 23(5):660-5. PubMed ID: 19674013
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Efficacy of tonsillectomy for patients with recurrence of IgA nephropathy after kidney transplantation.
    Ushigome H, Suzuki T, Fujiki M, Nobori S, Sakamoto S, Okamoto M, Urasaki K, Yoshimura N.
    Clin Transplant; 2009 Aug; 23 Suppl 20():17-22. PubMed ID: 19594590
    [Abstract] [Full Text] [Related]

  • 27. Impact of recurrent disease and chronic allograft nephropathy on the long-term allograft outcome in patients with IgA nephropathy.
    Han SS, Huh W, Park SK, Ahn C, Han JS, Kim S, Kim YS.
    Transpl Int; 2010 Feb; 23(2):169-75. PubMed ID: 19761553
    [Abstract] [Full Text] [Related]

  • 28. [Variable number of tandem repeats polymorphism of MUC20 is associated with the progression of IgA nephropathy].
    Li GS, Zhang H, Lü JC, Hou P, Zhou Y, Ma XZ, Wang HY.
    Zhonghua Yi Xue Za Zhi; 2005 May 25; 85(19):1333-8. PubMed ID: 16029633
    [Abstract] [Full Text] [Related]

  • 29. Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients.
    Pardon A, Audard V, Caillard S, Moulin B, Desvaux D, Bentaarit B, Remy P, Sahali D, Roudot-Thoraval F, Lang P, Grimbert P.
    Nephrol Dial Transplant; 2006 Apr 25; 21(4):1053-9. PubMed ID: 16364987
    [Abstract] [Full Text] [Related]

  • 30. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
    Pietrzak-Nowacka M, Safranow K, Dziewanowski K, Debska-Slizień A, Głyda M, Gołembiewska E, Jankowska M, Nowosiad M, Rutkowski B, Ciechanowski K.
    Ann Acad Med Stetin; 2008 Apr 25; 54(1):41-8. PubMed ID: 19127808
    [Abstract] [Full Text] [Related]

  • 31. IgA nephropathy as a donor-transmitted disease in renal transplant recipients.
    Koselj M, Rott T, Vizjak A, Kveder R.
    Transplant Proc; 1991 Oct 25; 23(5):2643-6. PubMed ID: 1926514
    [No Abstract] [Full Text] [Related]

  • 32. Long-term outcomes of kidney transplantation in recipients 60 years of age and older at the University of Florida.
    Foley DP, Patton PR, Meier-Kriesche HU, Li Q, Shenkman B, Fujita S, Reed A, Hemming AW, Kim RD, Howard RJ.
    Clin Transpl; 2005 Oct 25; ():101-9. PubMed ID: 17424728
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of tonsillectomy before kidney transplantation in patients with IgA nephropathy.
    Sato Y, Ishida H, Shimizu T, Tanabe K.
    Transpl Immunol; 2014 Jan 25; 30(1):12-7. PubMed ID: 24246415
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
    Nordén G, Briggs D, Cockwell P, Lipkin G, Mjörnstedt L, Mölne J, Ready A, Rydberg L, Samuelsson O, Svalander CT, Breimer ME.
    Xenotransplantation; 2006 Mar 25; 13(2):148-53. PubMed ID: 16623810
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Progression of renal allograft histology after renal transplantation in recurrent and nonrecurrent immunoglobulin A nephropathy.
    Jeong HJ, Park SK, Cho YM, Kim MS, Kim YS, Choi J, Kim SI, Lim BJ.
    Hum Pathol; 2008 Oct 25; 39(10):1511-8. PubMed ID: 18620732
    [Abstract] [Full Text] [Related]

  • 40. Histological differences in new-onset IgA nephropathy between children and adults.
    Ikezumi Y, Suzuki T, Imai N, Ueno M, Narita I, Kawachi H, Shimizu F, Nikolic-Paterson DJ, Uchiyama M.
    Nephrol Dial Transplant; 2006 Dec 25; 21(12):3466-74. PubMed ID: 16935895
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 50.